Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials (For debate)

Diabetologia. 2000 Apr;43(4):528-32.

Authors

B Richter¹, M Berger

Affiliation

¹ Department of Metabolic Diseases and Nutrition (WHO Collaborating Centre for Diabetes), Heinrich-Heine University, Düsseldorf, Germany.

PMID: 10819251

No abstract available

Publication types

Corrected and Republished Article
Research Support, Non-U.S. Gov't

MeSH terms

Coronary Disease / complications
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / drug therapy*
Diabetic Angiopathies
Evidence-Based Medicine
Humans
Hypoglycemic Agents / therapeutic use*
Quality Assurance, Health Care
Randomized Controlled Trials as Topic*
Safety
Treatment Outcome

Substances

Hypoglycemic Agents